GlassScriptPhysician profile
Brittany Calvert
NPI 1356842710
$813.64
in general payments reported to CMS, 2019-2025
16 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.84 · 2022: $122 · 2023: $264 · 2024: $81.27 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $143.51 | 2025 | |
| Axsome Therapeutics, INC. | $143.01 | 2023-2024 | Auvelity |
| Novartis Pharmaceuticals Corporation | $103.31 | 2025 | |
| Ucb, INC. | $67.13 | 2025 | Rystiggo, Briviact |
| Lilly USA, LLC | $57.44 | 2022-2023 | Jardiance, Mounjaro |
| Novo Nordisk INC | $55.06 | 2022-2023 | Wegovy, Ozempic, Rybelsus |
| Exact Sciences Corporation | $45.13 | 2023-2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $42.20 | 2021-2022 | |
| Amgen INC. | $29.87 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $21.70 | 2022 | |
| Corium, LLC | $19.91 | 2023 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $18.98 | 2023 | Rexulti |
| Pfizer INC. | $18.12 | 2024 | |
| Alexion Pharmaceuticals, INC. | $16.37 | 2025 | Ultomiris |
| Glaxosmithkline, LLC. | $16.17 | 2024 | Trelegy Ellipta, Arexvy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $15.73 | 2023 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Calvert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.